Announcements Trials
Browse Landscape

Status

Recruiting 2Active not recruiting 2Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 2Thoracic 2Gastrointestinal 2Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Neoplasms 2Neoplasm Metastasis 1

Interventions

pembrolizumab 17Specimen Handling 9Magnetic Resonance Spectroscopy 9Bevacizumab 8Paclitaxel 7Biopsy 7Nivolumab 6atezolizumab 5Surveys and Questionnaires 4Standard of Care 4Radiosurgery 4Practice Guidelines as Topic 4Pemetrexed 4Oxaliplatin 4Cyclophosphamide 4Carboplatin 4osimertinib 3niraparib 3durvalumab 3cemiplimab 3avelumab 3Radiotherapy 3Radiation 3Leucovorin 3Irinotecan 3Ipilimumab 3Interviews as Topic 3Fluorouracil 3trastuzumab deruxtecan 2trametinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Hematologic Tests × Tumor-Agnostic × Clear all
NCT03409016 2025-09-05

Biomarkers of Immune-Related Toxicity

University of Colorado, Denver

Active not recruiting
69 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06979921 2025-08-14

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

The First Affiliated Hospital with Nanjing Medical University

Active not recruiting
496 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡